Skip to main content

Circulomics-logo

Circulomics today announced a $1.5 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute of General Medical Sciences to create nucleic acid extraction products based on its Nanobind technology.

The firm said in a statement that it would use the grant to develop Nanobind technologies for automated and microvolume clinical sample preparation. It is building a pipeline of chemistries to extract DNA and RNA from sample types including cultured cells, blood, and other fluids, and from pathogens.

{iframe}https://www.genomeweb.com/research-funding/circulomics-wins-15m-phase-ii-sbir-grant-dnarna-extraction-tech{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.